BIT vs IMR

ASX Healthcare sector comparison — updated 26 Mar 2026 — Healthcare sector

BIT

BIOTRON FPO [BIT]

45LOW

IMR

IMRICOR CDI FORUS [IMR]

45LOW

Score Breakdown

BIT IMR
Technical
37
61
Catalyst
50
50
Sentiment
50
50
Fundamental
38
55
Momentum
69
58
Risk Gate
35
45

Key Metrics

BIT Metric IMR
$8.1MMarket Cap$635.5M
3.3MAvg Volume (20d)378K
N/AShort Interest+0.1%
$0.00552-Week High$2.250
$0.00252-Week Low$1.115
+0.0%Daily Change+2.3%
$0.003Entry Price$1.985
-122.6%ROE-1221.3%
N/AProfit MarginN/A

Active Signals

BIT Signals

MACD momentum is picking up steam
Stochastic is stretched into overbought — could need a breather
Volume surging at 2.2x normal while price falls — heavy selling pressure
Beating the Small Ords index — relative strength of 1.12, so it's outpacing the pack
Volume-price trend suggests distribution — sellers may be sneaking out while price holds
Volatility is expanding fast — choppy price action, so buckle up
Below the 200-day average — the long-term trend is still working against it
Low cash runway (3 quarters) - dilution risk

IMR Signals

Trading above the 200-day average — the long-term trend is on your side
Strong cash runway (9 quarters)
Very high P/S ratio (2174.0x)
Revenue in sharp decline (-83%)
Piotroski F-Score weak (3/9, low-confidence approx)
CANSLIM I: Institutional ownership (18%)
Not enough chatter to gauge sentiment — defaulting to neutral
Sentiment is mixed — no strong consensus either way

Ask Scout AI to compare BIT and IMR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener
BIT Full Analysis → IMR Full Analysis → Healthcare Sector →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).